ScienceDex / Researcher record
Schultz, Michael King
- Viewpoint Molecular Targeting, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2013 | $150,594 | 1 | #34,068 |
| 2014 | $150,594 | 1 | #34,054 |
| 2015 | $150,594 | 1 | #33,952 |
| 2016 | $150,594 | 1 | #34,444 |
| 2017 | $150,594 | 1 | #34,858 |
| 2021 | $1,998,531 | 2 | #3,460 |
| 2022 | $976,668 | 1 | #10,139 |
| 2023 | $948,099 | 1 | #10,934 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20131 record
- FY20141 record
- FY20151 record
- FY20161 record
- FY20171 record
- FY20212 records
- FY20221 record
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Schultz, Michael King as a PI. Multi-PI records show the full award amount for context.
- 5R44CA232954-03R44Contact PICombining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma$948.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Schultz, Michael King as a PI.
FY2023 award administered by Viewpoint Molecular Targeting, Inc. (IA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardViewpoint Molecular Targeting, Inc.
- 2016$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #3460
- 2021Entered Top 25% NationallyRanked #3460